Hedge Fund - Partner Fund Management
Elevance Health Inc. (ELV)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $0 | 0% | 0 | $337.93 |
| 2 | 2025 - Q3 (2025-09-30) | $19,637,941 | 1.51% | 60,776 | $311.02 |
| 3 | 2025 - Q2 (2025-06-30) | $0 | 0% | 0 | $402.22 |
| 4 | 2025 - Q1 (2025-03-31) | $38,373,041 | 2.79% | 88,222 | $401.43 |
| 5 | 2024 - Q4 (2024-12-31) | $0 | 0% | 0 | $418.46 |
| 6 | 2024 - Q3 (2024-09-30) | $29,349,320 | 1.66% | 56,441 | $534.22 |
| 7 | 2024 - Q2 (2024-06-30) | $29,937,765 | 1.48% | 55,250 | $528.58 |
| 8 | 2024 - Q1 (2024-03-31) | $28,649,335 | 1.34% | 55,250 | $497.33 |
| 9 | 2023 - Q4 (2023-12-31) | $22,484,452 | 1.34% | 47,681 | $462.41 |
| 10 | 2023 - Q3 (2023-09-30) | $10,681,288 | 0.5% | 24,531 | $453.58 |
| 11 | 2023 - Q2 (2023-06-30) | $33,375,953 | 1.29% | 75,122 | $461.32 |
| 12 | 2023 - Q1 (2023-03-31) | $14,981,989 | 0.66% | 32,583 | $475.89 |
| 13 | 2022 - Q4 (2022-12-31) | $34,427,982 | 1.23% | 67,115 | $507.74 |
| 14 | 2022 - Q3 (2022-09-30) | $11,719,000 | 0.42% | 25,800 | $478.49 |
| 15 | 2022 - Q2 (2022-06-30) | $20,623,000 | 0.78% | 42,734 | $494.71 |
| 16 | 2022 - Q1 (2022-03-31) | $20,992,000 | 0.78% | 42,734 | $457.10 |
| 17 | 2021 - Q4 (2021-12-31) | $19,809,000 | 0.67% | 42,734 | $420.70 |
| 18 | 2021 - Q1 (2021-03-31) | $0 | 0% | 0 | $321.58 |
| 19 | 2020 - Q4 (2020-12-31) | $52,735,000 | 1.85% | 164,238 | $306.88 |
| 20 | 2020 - Q3 (2020-09-30) | $27,787,000 | 1.28% | 103,455 | $269.07 |
| 21 | 2020 - Q2 (2020-06-30) | $26,298,000 | 1.36% | 100,000 | $266.78 |
| 22 | 2020 - Q1 (2020-03-31) | $50,840,000 | 4.17% | 223,925 | $272.52 |
| 23 | 2019 - Q4 (2019-12-31) | $59,967,000 | 2.85% | 198,548 | $275.19 |
| 24 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $273.99 |
| 25 | 2019 - Q2 (2019-06-30) | $53,399,000 | 1.01% | 189,219 | $273.16 |
| 26 | 2019 - Q1 (2019-03-31) | $99,409,000 | 2.19% | 346,397 | $289.21 |
| 27 | 2018 - Q4 (2018-12-31) | $118,557,000 | 3.15% | 451,421 | $274.98 |
| 28 | 2018 - Q3 (2018-09-30) | $145,710,000 | 2.13% | 531,690 | $259.59 |
| 29 | 2018 - Q2 (2018-06-30) | $168,345,000 | 2.63% | 707,244 | $231.57 |
| 30 | 2018 - Q1 (2018-03-31) | $145,193,000 | 2.95% | 660,870 | $234.91 |
| 31 | 2017 - Q4 (2017-12-31) | $60,259,000 | 1.42% | 267,805 | $212.98 |
| 32 | 2017 - Q3 (2017-09-30) | $120,065,000 | 2.35% | 632,321 | $190.32 |
| 33 | 2017 - Q2 (2017-06-30) | $104,472,000 | 2.81% | 555,316 | $179.68 |
| 34 | 2017 - Q1 (2017-03-31) | $72,788,000 | 1.82% | 440,126 | $159.07 |
| 35 | 2016 - Q4 (2016-12-31) | $77,126,000 | 2.17% | 536,457 | $133.90 |
| 36 | 2016 - Q2 (2016-06-30) | $0 | 0% | 0 | $136.83 |
| 37 | 2016 - Q1 (2016-03-31) | $72,123,000 | 2.22% | 518,909 | $133.63 |
| 38 | 2015 - Q3 (2015-09-30) | $0 | 0% | 0 | $150.29 |
| 39 | 2015 - Q2 (2015-06-30) | $84,321,000 | 2.13% | 513,715 | $159.77 |
The displayed share prices are average quarterly stock market prices.